Left Menu
Development News Edition

Biocon highlights details of its drug Itolizumab approved as life-saving COVID-19 medicine

"It is the first novel biological therapy to be approved by the DCGI for treating patients with moderate to severe COVID-19 complications," the executive chairperson of the company Kiran Mazumdar Shaw said at a press conference. Claiming that Itolizumab is a drug to save many lives, she said the DCGI gave permission for Biocon to market Itolizumab.

PTI | Bengaluru | Updated: 13-07-2020 16:36 IST | Created: 13-07-2020 16:36 IST
Biocon highlights details of its drug Itolizumab approved as life-saving COVID-19 medicine

Bengaluru based biotech major Biocon on Monday announced that its drug Itolizumab, which will hit the market as ALZUMAb, has received permission from the Drugs Controller General of India for use in moderate to severe COVID-19 patients. "It is the first novel biological therapy to be approved by the DCGI for treating patients with moderate to severe COVID-19 complications," the executive chairperson of the company Kiran Mazumdar Shaw said at a press conference.

Claiming that Itolizumab is a drug to save many lives, she said the DCGI gave permission for Biocon to market Itolizumab. "It is an injection containing 25mg/5mL solution for emergency use in India for the treatment of Cytokine Release Syndrome (CRS) in moderate to severe acute respiratory distress syndrome (ADRS) patients caused by the COVID-19," the Biocon chairperson said.

Shaw said the therapy costing Rs 32,000 is given to the patient in four vials with each vial priced at Rs 8,000. Itolizumab is a clinically proven therapy for the COVID-19 patients with ARDS, she said,adding that the drug has got successful results from a multi-centric, two armed randomised pivotal trial conducted to study the efficacy and safety of Itolizumab in COVID-19 complications.

"Itolizumab is a breakthrough. The beauty of this drug is it is working upstream, which means it actually starts regulating the immune system, rebooting the immune system and it starts down regulating the immune system, saying, do not make such pro-inflammatory cytokines start slowing down," Shaw said.

She added that the body then recovers completely to fight the virus. "By effectively controlling therefore hyper activation of the immune system prevents morbidity and mortality related to the cytokine storm," she added.

According to her, this is an original innovative Indian drug, which Biocon has licenced from Cuba 20 years ago. "And we developed it in India.We actually did a lot of research in India.

We actually did clinical trials in India, and it is made in India, innovated in India, drug, which we have licenced to a US company, which is also doing trials with the drug. And we are very proud that this is actually an original first in class drug," Shaw said. Stating that there is no other company in the world that has an anti-CD6 antibody, Shaw said Itolizumab is a unique drug.PTI GMS BN WELCOME BN WELCOME


TRENDING

OPINION / BLOG / INTERVIEW

5G will be the key driving force for COVID-19 recovery: Here's how?

... ...

Canada’s COVID-19 pitfalls highlight need for integrated health information system

In the globalized world of today where outbreaks can spread far and wide within a matter of days, a global-level integrated health information system is ideal but Canadas provincial barriers show that the country lags much behind in deployi...

Pandemic must be impetus, not obstacle, for clean water access

To make matters worse, there are suspicions that the inadequacy of wastewater treatment methods in California, the rest of the USA, and indeed around the world may help to propagate the disease even more widely. ...

3D printing and the future of manufacturing post COVID-19

The on-demand, customizable, and localized manufacturing of product components facilitated by 3D printing has the potential to redefine manufacturing but there are certain technical, mechanical, and legal limitations that, unless ...

Videos

Latest News

Locally produced vehicles and weapons will help to fight against Boko Haram, says DICON

The Defence Industries Corporation of Nigeria DICON says light tactical vehicles and other weapons being locally produced by its company, will help in addressing Nigerias internal security challenges especially in the fight against Boko Har...

Torrential rain causes landslide in Nepal, 5 dead, 38 missing

At least five people have died and 38 went missing after torrential rain caused a landslide in Sindhupalchok district of Nepal on Friday early morning.We have found five bodies from the debris after the landslide swept houses this morning a...

I was lucky to have support from family and IAF: Gunjan Saxena

Former IAF officer Gunjan Saxena, whose life story has been made into a Netflix feature film, says she was lucky to have the support of commanding officers and supervisors in the Indian Air Force but whenever there is a major change in an o...

Belarusian opposition politician Tsikhanouskaya asks supporters to back vote recount

Belarusian opposition politician Sviatlana Tsikhanouskaya on Friday asked supporters to sign an online form demanding a recount of last Sundays presidential election in which she believes she was swindled out of victory. In a video posted o...

Give Feedback